Search - tctmd.com

Displaying 201 - 219 of 219

Sort: Relevancy | Date

News Conference News ACC 2012

PARTNER: TAVR Remains as Effective as Surgery at 2 Years

March 26, 2012

News Conference News ACC 2012

Coronary CTA Effective, Efficient in Ruling Out Patients With Suspected ACS

March 26, 2012

News Daily News

Se Publica el CLOSURE I mientras siguen en Marcha Similares Ensayos del FOV

March 15, 2012

News Daily News

TCTMD’s Top 10 Most Popular News Stories From 2011

March 08, 2012

News Daily News

Los 10 Artículos Más Populares de TCTMD de 2011

March 08, 2012

News Daily News

FDA, CMS Parallel Review Aims to Speed Access to Innovative Technologies

October 14, 2011

News Conference News

Apixaban Bests Warfarin in Stroke Prevention for Atrial Fib

August 28, 2011

News Daily News

NEJM Articles Argue to Sack FDA’s Device Clearance Process

August 12, 2011

News Daily News

FDA Panel Recommends Approval of Transcatheter Heart Valve

July 21, 2011

News Daily News

PARTNER Cohort A Published: Surgical Candidates Obtain Similar 1-Year Survival with TAVI, Surgery

June 07, 2011

News Daily News

PARTNER Finds Higher Rate of Neurological Events with TAVI vs. Surgery

May 13, 2011

News Daily News

The COURAGE Effect: Sustained Decline Seen in PCI for Stable Angina

April 25, 2011

News Conference News

PARTNER: In High-Risk Surgical Candidates, TAVI Proves Just as Effective

April 03, 2011

News Daily News

Meta-analysis: Renal Intervention Reduces BP Drugs, Not Outcomes

March 18, 2011

News Daily News

New Carotid Disease Guidelines Take Cues from CREST

January 31, 2011

News Daily News

NEJM Letters Take on PARTNER Trial

January 11, 2011

News Industry News

Bayer’s Rivaroxaban Submitted for EU Marketing Authorisation in Stroke Prevention in Patients with Atrial Fibrillation as well as for the Treatment of Deep Vein Thrombosis

January 04, 2011

Latest Data on Left Main Stenting and its Implications

CME

Latest Data on Left Main Stenting and its Implications

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.